Sierra Medical Secures Over RMB 100 Million in New Funding Round Led by Qianji Capital and Shunwei Capital to Advance Ophthalmic Surgical Platforms

Investment Circle (ID: pedaily2012) September 2nd, by reporter, Sierra Medical, a portfolio company of Hony Capital, has completedOver 100 Million YuanFinancing. This round of financing was led byQianji Capital, Shunwei CapitalCo-led by, existing shareholdersBoxin Capital, Hony CapitalContinuously increasing.

The funds from this round of financing will be mainly used for the in-depth research and development of the company's first self-developed phacoemulsification and vitrectomy integrated machine product line. At the same time, it will further enrich the company's ophthalmic surgical equipment product portfolio, accelerate the import substitution of high-end domestically produced ophthalmic devices, and expedite the overseas expansion of the company’s ophthalmic products.

Sierra Medical was founded in July 2022. The company's core team has extensive industry experience and possesses complete R&D, production, and commercialization capabilities. Focused on providing precise, intelligent, minimally invasive surgical treatment solutions for ophthalmology, Sierra Medical is committed to breaking the monopoly of foreign enterprises in the high-end ophthalmic surgical instruments field and addressing the "bottleneck" issue of critical surgical instruments. Currently, its products under development mainly include advanced ophthalmic surgical instruments such as phacoemulsification and vitrectomy integrated machines and their accompanying consumables, as well as digital surgical microscopes. Sierra Medical is dedicated to offering innovative and high-quality products and services to ophthalmologists and patients, driving the advancement of ophthalmic medical technology.